NCT05752084View on ClinicalTrials.gov

Bilirubin Increases the Risk of Nosocomial Infection in Cirrhotic Patients

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Nosocomial Infection
Trial Locations (1)

Unknown

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT05752084 - Bilirubin Increases the Risk of Nosocomial Infection in Cirrhotic Patients | Biotech Hunter | Biotech Hunter